BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

20 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Bioventus to Expand Operations and Manufacturing in Memphis

18 Nov 2021 07:45:00 By Nasdaq GlobeNewswire

Bioventus Announces Chief Financial Officer Transition Plan

15 Nov 2021 06:30:01 By Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

09 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs

01 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Bioventus Completes the Acquisition of Misonix

29 Oct 2021 07:25:18 By Nasdaq GlobeNewswire

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

27 Oct 2021 15:15:00 By Nasdaq GlobeNewswire

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

26 Oct 2021 15:15:00 By Nasdaq GlobeNewswire

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons

20 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Bioventus Proceeds with Option Structure Agreement with CartiHeal

30 Aug 2021 06:30:00 By Nasdaq GlobeNewswire

Bioventus Invests in Trice Medical Minimally Invasive Technologies

25 Aug 2021 15:05:00 By Nasdaq GlobeNewswire

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

23 Aug 2021 07:30:00 By Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance

10 Aug 2021 15:05:02 By Nasdaq GlobeNewswire

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

29 Jul 2021 15:05:01 By Nasdaq GlobeNewswire

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

29 Jul 2021 15:00:00 By Nasdaq GlobeNewswire

Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

27 Jul 2021 15:15:00 By Nasdaq GlobeNewswire

Bioventus Appoints Mary Kay Ladone to Board of Directors

14 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide

13 Jul 2021 07:30:00 By Nasdaq GlobeNewswire

Bioventus Invests in Vaporox

24 Jun 2021 15:36:41 By Nasdaq GlobeNewswire